The estimated Net Worth of Dan Groman is at least $2.25 Million dollars as of 14 November 2023. Mr Groman owns over 5,000 units of Enfusion stock worth over $1,077,315 and over the last 2 years he sold ENFN stock worth over $1,168,465.
Sign up
Mr Groman ENFN stock SEC Form 4 insiders trading
Mr has made over 16 trades of the Enfusion stock since 2022, according to the Form 4 filled with the SEC. Most recently he sold 5,000 units of ENFN stock worth $49,850 on 14 November 2023.
The largest trade he's ever made was selling 53,877 units of Enfusion stock on 22 May 2023 worth over $426,706. On average, Mr trades about 5,093 units every 15 days since 2022. As of 14 November 2023 he still owns at least 133,828 units of Enfusion stock.
You can see the complete history of Mr Groman stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mr. Daniel Groman biography
Daniel Groman is the MD & CTO at Enfusion.
How old is Mr Groman?
Mr Groman is 33, he's been the MD & CTO of Enfusion since . There are 4 older and no younger executives at Enfusion. The oldest executive at Enfusion, Inc. is Tarek Hammoud, 55, who is the Co-Founder & Exec. Chairman.
What's Mr Groman's mailing address?
Dan's mailing address filed with the SEC is C/O ENFUSION, INC., 125 SOUTH CLARK STREET SUITE 750, CHICAGO, IL, 60603.
Insiders trading at Enfusion
Over the last 3 years, insiders at Enfusion have traded over $144,301,080 worth of Enfusion stock and bought 2,523,188 units worth $42,894,196 . The most active insiders traders include Investment Management, Ltd...., Bradford Eftv Iv, L.P. Bern... und Tarek Lra Ventures, Llc Ham.... On average, Enfusion executives and independent directors trade stock every 22 days with the average trade being worth of $2,488,344. The most recent stock trade was executed by Valeria Gutowski on 18 June 2024, trading 1,258 units of ENFN stock currently worth $10,278.
What does Enfusion's logo look like?
Complete history of Mr Groman stock trades at Enfusion
Enfusion executives and stock owners
Enfusion executives and other stock owners filed with the SEC include:
-
Bronwen Bastone,
Chief People Officer -
Lorelei M. Skillman,
Chief Marketing Officer -
Brian Murphy,
Investor -
Daniel Groman,
MD & CTO -
Alan Polo,
Head of Account Management -
Michael Berry,
Chief Operating Officer -
Stephen P. Dorton,
Chief Financial Officer -
Stephen Malherbe,
Managing Partner -
Thomas Kim,
Chief Exec. Officer -
Tarek Hammoud,
Co-Founder & Exec. Chairman -
Steven M. Bachert,
Chief Revenue Officer -
Bradley Herring,
Chief Financial Officer -
Michael Spellacy,
Director -
Deirdre Somers,
Director -
Matthew Campobasso,
General Counsel -
Neal Pawar,
Chief Operating Officer -
Stephen Malherbe Investment...,
-
Lawrence E Leibowitz,
Director -
Bradford Eftv Iv, L.P. Bern...,
-
Oleg Movchan,
Director -
Oleg Csl Tech Holdings Llc ...,
Chief Executive Officer -
Investment Management, Ltd....,
10% owner -
Tarek Hammoud,
Director -
Strategic Partners V, L.P.I...,
-
Roy Luo,
Director -
Jan Hauser,
Director -
Kathleen De Rose,
Director -
Thomas Kim,
Chief Executive Officer -
Lorelei M. Skillman,
Chief Mrktg. & Comm. Officer -
Stephen M Dorton,
Chief Financial Officer -
Bronwen Bastone,
Chief People Officer -
Dan Groman,
Chief Technology Officer -
Tarek Lra Ventures, Llc Ham...,
-
Oleg Quiet Light Securities...,
Chief Executive Officer -
Valeria Gutowski,
Chief Accounting Officer